These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10394473)

  • 1. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia.
    Moore H; West AR; Grace AA
    Biol Psychiatry; 1999 Jul; 46(1):40-55. PubMed ID: 10394473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
    Abi-Dargham A; Moore H
    Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive memory systems and category learning in schizophrenia.
    Kéri S
    Neurosci Biobehav Rev; 2008; 32(2):206-18. PubMed ID: 17854895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forebrain dopamine systems--can they help us to understand psychosis?
    Grace A
    Eur Psychiatry; 2003 Dec; 18 Suppl 2():27s-31s. PubMed ID: 23570193
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a Unifying Cognitive, Neurophysiological, and Computational Neuroscience Account of Schizophrenia.
    Heinz A; Murray GK; Schlagenhauf F; Sterzer P; Grace AA; Waltz JA
    Schizophr Bull; 2019 Sep; 45(5):1092-1100. PubMed ID: 30388260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia.
    Deakin JF; Slater P; Simpson MD; Gilchrist AC; Skan WJ; Royston MC; Reynolds GP; Cross AJ
    J Neurochem; 1989 Jun; 52(6):1781-6. PubMed ID: 2566649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
    Goto Y; Grace AA
    Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis.
    Kurachi M
    Psychiatry Clin Neurosci; 2003 Feb; 57(1):9-15. PubMed ID: 12519449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From real-world events to psychosis: the emerging neuropharmacology of delusions.
    Morrison PD; Murray RM
    Schizophr Bull; 2009 Jul; 35(4):668-74. PubMed ID: 19487337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
    Tanaka S
    Neuroscience; 2006 Apr; 139(1):153-71. PubMed ID: 16324800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increase in [3H]SCH23390 binding in the cerebral cortex of postmortem brains of chronic schizophrenics.
    Domyo T; Kurumaji A; Toru M
    J Neural Transm (Vienna); 2001; 108(12):1475-84. PubMed ID: 11810409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study.
    Goldsmith SK; Shapiro RM; Joyce JN
    Arch Gen Psychiatry; 1997 Jul; 54(7):649-58. PubMed ID: 9236549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
    Deakin FW; Simpson MD; Slater P; Hellewell JS
    J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological models of schizophrenia: an update].
    Lotstra F
    Encephale; 2006; 32(4 Pt 1):446-51. PubMed ID: 17099555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
    Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.